Simplex Trading
STOK icon

Simplex Trading’s Stoke Therapeutics STOK Stock Holding History

Simplex Trading’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$3.26K – 10271
2026
Q1 		$3.26K Sell
100
-28,400
-100% -$931K ﹤0.01% 8138
2025
Q4 		$905K Buy
28,500
+25,300
+791% +$761K ﹤0.01% 2724
2025
Q3 		$75K Buy
3,200
+900
+39% +$15.4K ﹤0.01% 6058
2025
Q2 		$26K Sell
2,300
-1,600
-41% -$15.2K ﹤0.01% 6543
2025
Q1 		$25K Buy
+3,900
New +$36.4K ﹤0.01% 6408
2024
Q4 		– Sell
-3,800
Closed -$46K – 9577
2024
Q3 		$46K Buy
3,800
+2,000
+111% +$28.3K ﹤0.01% 5956
2024
Q2 		$24K Sell
1,800
-23,200
-93% -$313K ﹤0.01% 6748
2024
Q1 		$337K Buy
+25,000
New +$151K ﹤0.01% 4256
2023
Q3 		– Sell
-100
Closed -$1K – 9776
2023
Q2 		$1K Buy
+100
New +$1.06K ﹤0.01% 8725
2021
Q2 		– Sell
-7
Closed -$27K – 10685
2021
Q1 		$27K Buy
7
+6
+600% +$342 ﹤0.01% 7223
2020
Q4 		$6K Buy
+1
New +$46 ﹤0.01% 7670

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Simplex Trading's STOK Position: Q2 2026 in Review

Simplex Trading sold out of Stoke Therapeutics (STOK) in Q2 2026, closing a stake of 130 shares — an estimated $4.23K sold.

Simplex Trading first reported a position in STOK in Q1 2020 and held it in 18 quarters. The position peaked at $537K in Q2 2023. 198 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Simplex Trading reported no remaining Stoke Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 130 Stoke Therapeutics shares in Q2 2026, an estimated $4.23K.
  • Simplex Trading first reported a position in Stoke Therapeutics in Q1 2020 and held it in 18 quarters.
  • Simplex Trading's Stoke Therapeutics position peaked at $537K in Q2 2023.
  • 198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.